Literature DB >> 28375551

Phenotypic characterization of regulatory T cells from antiretroviral-naive HIV-1-infected people.

Georgia N Ambada1,2, Claudine E Ntsama2, Nadesh N Nji1, Loveline N Ngu1,3, Carole N Sake1,3, Abel Lissom1,2, Flaurent T Tchouangeu1,4, Jules Tchadji1,2, Martin Sosso1, François-Xavier Etoa5, Godwin W Nchinda1.   

Abstract

Regulatory T (Treg) cells play a key role in dampening excessive immune activation. However, antiretroviral therapy (ART) -naive HIV-1 infection maintains the immune system in a sustained state of activation that could alter both Treg cell surface markers and functions. As Treg cell surface markers are directly linked to their functions the overall objective of this study was to determine how ART-naive HIV infection affects the phenotypic properties of Treg cells. Our data showed that in ART-naive HIV-1 infection, Treg cells are dominated by effector (CD45RA+  CD27-  CCR7- CD62L- ) and effector memory (CD45RA-  CD27-  CCR7-  CD62L- ) cells. In contrast Treg cells from HIV-negative individuals were mainly naive (CD45RA+  CD27+  CCR7+  CD62L+ ) and central memory (CD45RA- CD27+  CCR7+  CD62L+ ) cells. Whereas effector and effector memory Treg cells showed enhanced expression of CD39 (P < 0·05), CD73 (P < 0·001), HLA-DR and CD38 (P < 0·001); naive and central memory Treg cells showed a significant reduction in the expression of these markers. Overall Treg cell frequencies within total CD4+ T cells correlated positively with plasmatic HIV-1 viral load. As increased viral load is associated with augmented CD4+ T-cell destruction; this could suggest a resistance of peripheral Treg cells to HIV-1 destruction. Hence the modulation of Treg cell phenotype and frequencies could be considered in designing immunotherapeutic strategies targeting immune system restoration during HIV-1 infection.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  antiretroviral therapy-naive HIV infection; phenotype; regulatory T cells; sustained activation

Mesh:

Substances:

Year:  2017        PMID: 28375551      PMCID: PMC5506422          DOI: 10.1111/imm.12738

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  40 in total

1.  Normalization of FoxP3(+) regulatory T cells in response to effective antiretroviral therapy.

Authors:  Martin Montes; Cesar Sanchez; Dorothy E Lewis; Edward A Graviss; Carlos Seas; Eduardo Gotuzzo; A Clinton White
Journal:  J Infect Dis       Date:  2010-12-21       Impact factor: 5.226

2.  Immunoregulatory T cells may be involved in preserving CD4 T cell counts in HIV-infected long-term nonprogressors and controllers.

Authors:  Julie C Gaardbo; Andreas Ronit; Hans J Hartling; Lise M R Gjerdrum; Karoline Springborg; Elisabeth Ralfkiær; Kristina Thorsteinsson; Henrik Ullum; Åse B Andersen; Susanne D Nielsen
Journal:  J Acquir Immune Defic Syndr       Date:  2014-01-01       Impact factor: 3.731

Review 3.  The role of regulatory T cells in chronic and acute viral infections.

Authors:  Yoav Keynan; Catherine M Card; Paul J McLaren; Magdy R Dawood; Ken Kasper; Keith R Fowke
Journal:  Clin Infect Dis       Date:  2008-04-01       Impact factor: 9.079

4.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

5.  Regulatory T cells in human immunodeficiency virus-infected patients are elevated and independent of immunological and virological status, as well as initiation of highly active anti-retroviral therapy.

Authors:  J C Gaardbo; S D Nielsen; S J Vedel; A K Ersbøll; L Harritshøj; L P Ryder; J O Nielsen; L Kolte
Journal:  Clin Exp Immunol       Date:  2008-10       Impact factor: 4.330

6.  Human regulatory T cells are targets for human immunodeficiency Virus (HIV) infection, and their susceptibility differs depending on the HIV type 1 strain.

Authors:  Maria E Moreno-Fernandez; Wildeman Zapata; Jason T Blackard; Genoveffa Franchini; Claire A Chougnet
Journal:  J Virol       Date:  2009-10-14       Impact factor: 5.103

7.  CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load.

Authors:  Ana E Sousa; Jorge Carneiro; Martin Meier-Schellersheim; Zvi Grossman; Rui M M Victorino
Journal:  J Immunol       Date:  2002-09-15       Impact factor: 5.422

8.  Characteristics and PD-1 expression of peripheral CD4+CD127loCD25hiFoxP3+ Treg cells in chronic HCV infected-patients.

Authors:  Tao Shen; Jiajia Zheng; Hua Liang; Chunhui Xu; Xiangmei Chen; Ting Zhang; Qiang Xu; Fengmin Lu
Journal:  Virol J       Date:  2011-06-07       Impact factor: 4.099

9.  CD4+FOXP3+ Regulatory T-Cell Subsets in Human Immunodeficiency Virus Infection.

Authors:  Federico Simonetta; Christine Bourgeois
Journal:  Front Immunol       Date:  2013-07-30       Impact factor: 7.561

10.  CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status.

Authors:  Audrey L Kinter; Margaret Hennessey; Alicia Bell; Sarah Kern; Yin Lin; Marybeth Daucher; Maria Planta; Mary McGlaughlin; Robert Jackson; Steven F Ziegler; Anthony S Fauci
Journal:  J Exp Med       Date:  2004-07-26       Impact factor: 14.307

View more
  5 in total

1.  Mild hypothermia provides Treg stability.

Authors:  Natalia Marek-Trzonkowska; Karolina Piekarska; Natalia Filipowicz; Arkadiusz Piotrowski; Magdalena Gucwa; Katrin Vogt; Birgit Sawitzki; Janusz Siebert; Piotr Trzonkowski
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

Review 2.  Association of Diverse Genotypes and Phenotypes of Immune Cells and Immunoglobulins With the Course of HIV-1 Infection.

Authors:  Liuzhe Li; Yan Liu; Miroslaw K Gorny
Journal:  Front Immunol       Date:  2018-11-26       Impact factor: 7.561

3.  Purinergic Profiling of Regulatory T-cells in Patients With Episodic Migraine.

Authors:  Dilyara Nurkhametova; Igor Kudryavtsev; Olga Khayrutdinova; Maria Serebryakova; Rashid Altunbaev; Tarja Malm; Rashid Giniatullin
Journal:  Front Cell Neurosci       Date:  2018-09-25       Impact factor: 5.505

Review 4.  Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders.

Authors:  Jatin Machhi; Bhavesh D Kevadiya; Ijaz Khan Muhammad; Jonathan Herskovitz; Katherine E Olson; R Lee Mosley; Howard E Gendelman
Journal:  Mol Neurodegener       Date:  2020-06-05       Impact factor: 14.195

5.  Filaria specific antibody response profiling in plasma from anti-retroviral naïve Loa loa microfilaraemic HIV-1 infected people.

Authors:  Ghislain Donald Njambe Priso; Abel Lissom; Loveline N Ngu; Nadesh N Nji; Jules Colince Tchadji; Thibau Flaurant Tchouangueu; Georgia E Ambada; Carole Stéphanie Sake Ngane; Brigitte Laure Dafeu; Larissa Djukouo; Inès Nyebe; Suzanne Magagoum; Apeh Alfred Ngoh; Ouambo Fotso Herve; Rosario Garcia; Anna Gutiérrez; Arinze S Okoli; Charles O Esimone; Flobert Njiokou; Chae Gyu Park; Alain Bopda Waffo; Godwin W Nchinda
Journal:  BMC Infect Dis       Date:  2018-04-04       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.